SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2024 and November 12, 2025, inclusive (the "Class Period†), have until March 9, 2026 to seek appointment as lead plaintiff of the Ardent Health class action lawsuit. Captioned Postiwala v. Ardent Health, Inc., No. 26-cv-00022 (M.D. Tenn.), the Ardent Health class action lawsuit charges Ardent Health and certain of Ardent Health' ...

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant financial losses for investors during the specified class period [1][3]. Company Overview - Ardent Health, Inc. operates a network of hospitals and clinics providing various healthcare services [2]. Allegations of the Lawsuit - The lawsuit claims that Ardent Health did not rely on accurate methods for determining the collectability of accounts receivable, which allowed the company to report inflated financial figures [3]. - It is alleged that Ardent Health's accounts receivable framework utilized a "180-day cliff" for reserving accounts, delaying the recognition of losses on uncollectible accounts [3]. - The company reportedly lacked sufficient professional malpractice liability insurance and reserves to cover claims, particularly in light of increasing social inflationary pressures in the New Mexico market [3]. Financial Impact - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised accounts receivable collectability assessments and a new revenue accounting system [4]. - The company also cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $615 million to $530 million - $555 million, citing persistent industry-wide cost pressures [4]. - Additionally, a $54 million increase in professional liability reserves was recorded due to recent settlements and ongoing litigation, reflecting broader industry trends [4]. - Following these announcements, Ardent Health's stock price fell nearly 34% [4]. Legal Process - Investors who purchased Ardent Health securities during the class period can seek to be appointed as lead plaintiff in the lawsuit, representing the interests of the class [5]. - The lead plaintiff has the authority to select a law firm for litigation and does not need to be the lead plaintiff to share in any potential recovery [5]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has a strong track record in obtaining significant recoveries in securities class action cases, including the largest recovery in history [6].